Abstract:Background: Glycogen storage disease type I (GSD I), also known as von Gierk disease, is a metabolic disorder leading to the excessive accumulation of glycogen and fat in organs, characterized by hepatomegaly, hypoglycemia, lactic acidemia, hyperlipidemia, hyperuricemia, puberty delay and growth retardation, which can be indicated by height, weight, blood glucose and blood lipids. Case presentation: Here we present a 16-year-old male patient with GSD Ia complicated with hepatic adenoma and combined with hepatitis B. As a chronic hepatitis B patient, the patient was admitted to hospital in order to further clarify the nature of hepatic space occupancy because of suspicion of hepatocellular carcinoma. However, the imaging studies did not support hepatocellular carcinoma certainly. And by tracing his clinical history, we suggested that he might suffer from GSD I. Finally the diagnosis was confirmed by MRI (Gd-EOB-DTPA), liver biopsy and whole exome sequencing (WES). The WES discovered a homozygous point mutation at the exon 5 of G6PC gene at 17th chromosome, c.G648 T (p.L216 L, NM_000151, rs80356484). This pathogenic mutation causes CTG changing to CTT at protein 216. Though both codons encode leucine, this silent mutation creates a new splicing site 91 bp downstream of the authentic splice site. According to previous research, this mutation is a disease causal variant for GSD Ia, and has a high frequency among GSD patients in China and Japan. This patient was finally diagnosed as GSD Ia complicated with hepatic adenoma and combined with chronic hepatitis B, and received corn starch therapy immediately after GSD was suspected. After receiving corn starch therapy, the height and weight of the patient were increased, and the secondary sexual characteristics were developed, including beard, pubic hair and seminal emission. Unexpectedly, the liver adenomas were still increasing, and we did not find any cause to explain this phenomenon. Conclusion: This patient was diagnosed as GSD Ia combined with chronic hepatitis B, who responded to corn starch intervention. For childhood patients with hypoglycaemia, hyperlipidemia, puberty delay and growth retardation, GSD should be considered. Gene sequencing is valuable for the quick identification of GSD subtypes.

Molecular genetics of glycogen-storage disease type 1a in Chinese patients of Taiwan

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia

[Clinical Features and Acid Alpha-Glucosidase Gene Mutation in 7 Chinese Patients with Glycogen Storage Disease Type II].

The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis

Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia

Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IX

Genotypic and phenotypic characteristics of 12 chinese children with glycogen storage diseases

Molecular Genetics of Type 1 Glycogen Storage Disease

Mutations in the glucose-6-phosphatase gene of 53 Italian patients with glycogen storage disease type Ia

Report of 7 cases of glycogen storage disease type VI and type IXa

[Splicing abnormalities caused by a novel mutation in the PHKA2 gene in children with glycogen storage disease type IX]

Expanding the phenotype and metabolic basis of ATP6AP2-congenital disorder of glycosylation in a Chinese patient with a novel variant c.185G>A (p.Gly62Glu)

Expanding the clinicopathological-genetic spectrum of glycogen storage disease type IXd by a Chinese neuromuscular center

Identification of Eight Novel Mutations of the Acid Α-Glucosidase Gene Causing the Infantile or Juvenile Form of Glycogen Storage Disease Type II

A glycogen storage disease type 1a patient with type 2 diabetes

[AGL gene analysis of a pedigree with glycogen storage disease type III and identification of a novel mutation]

Misdiagnosis as steatohepatitis in a family with mild glycogen storage disease type 1a.

A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report

Clinical and Functional Characterization of Novel AGL Variants in Two Families with Glycogen Storage Disease Type III